A conexão entre ácidos biliares e diabetes mellitus tipo 2 - Uma revisão / The connection between bile acids and type 2 diabetes mellitus - a review

ABSTRACT Background: Bile acids (BAs) are steroid molecules synthesized exclusively in the liver, being end products of cholesterol catabolism. BAs are known to be involved in several metabolic alterations, including metabolic syndrome and type 2 diabetes mellitus (DM2). DM2 is a chronic degenerative disease characterized by insulin resistance, insulin deficiency due to insufficient production of pancreatic ß-cells, and elevated serum glucose levels leading to multiple complications. Objective: The objective of this study is to investigate the role of BAs in the pathophysiology of DM2, highlighting the possibilities in the development of therapeutic procedures targeting BAs as an optional pathway in the treatment of DM2. Methods: The research was carried out through narrative review and publications on the relationship between BAs and DM2. The databases used for the search include PubMed, Scopus, and Web of Science. The keywords used for the search include bile acids, type 2 diabetes mellitus, metabolic syndrome, and metabolic disorders. Results: The studies have reported the involvement of BAs in the pathophysiology of DM2. BAs act as a ligand for the nuclear farnesoid X receptor, regulating glucose metabolism, lipid metabolism, and cellular energy production. Additionally, BAs modulate the production, elimination, and mobilization of BAs through the farnesoid X receptor. BAs also act as a signaling pathway through Takeda G protein-coupled receptor 5, further contributing to metabolic regulation. These findings suggest that targeting BAs may offer a novel therapeutic approach in the treatment of DM2. Conclusion: This study highlights the important role of BAs in DM2, specifically through their interactions with key metabolic pathways. Targeting BAs may represent an innovative and effective approach to the treatment of DM2.

RESUMO Contexto: Os ácidos biliares (ABs) são moléculas esteróides sintetizadas exclusivamente no fígado, sendo produtos finais do catabolismo do colesterol. Os ABs são conhecidos por estarem envolvidos em várias alterações metabólicas, incluindo a síndrome metabólica e o diabetes mellitus tipo 2 (DM2). A DM2 é uma doença crônica degenerativa caracterizada pela resistência insulínica, deficiência de insulina devido à produção insuficiente de células ß pancreáticas e hiperglicemia levando a múltiplas complicações. Objetivo: O objetivo deste estudo é investigar o papel dos ABs na fisiopatologia da DM2, destacando as possibilidades no desenvolvimento de procedimentos terapêuticos visando os ABs como uma via opcional no tratamento da DM2. Métodos: A pesquisa foi realizada por meio de revisão narrativa e publicações sobre a relação entre ABs e DM2. As bases de dados usadas para a pesquisa incluem PubMed, Scopus e Web of Science. As palavras-chave usadas para a pesquisa incluíram: ácidos biliares, diabetes mellitus tipo 2, síndrome metabólica e distúrbios metabólicos. Resultados: Os estudos relataram o envolvimento dos ABs na fisiopatologia da DM2. Os ABs atuam como ligantes para o receptor nuclear farnesoide X, regulando o metabolismo da glicose, metabolismo lipídico e produção de energia celular. Além disso, os ABs regulam a produção, eliminação e mobilização de ABs através do receptor farnesoide X. Os ABs também atuam como uma via de sinalização através do receptor acoplado à proteína G Takeda 5, contribuindo ainda mais para a regulação metabólica. Esses achados sugerem que o ABs pode oferecer uma nova abordagem terapêutica no tratamento da DM2. Conclusão: Este estudo destaca o papel importante do ABs na DM2, especificamente por meio de suas interações com vias metabólicas-chave. O redirecionamento ao ABs pode representar uma abordagem inovadora e eficaz para o tratamento da DM2.

Rastreamento da doença renal do diabetes na atenção primária à saúde / Screening for diabetes kidney disease in primary health care

A Doença Renal do Diabetes (DRD) é assintomática nos estágios iniciais da doença, e por esse motivo, a maioria dos pacientes é diagnosticada somente quando já apresenta várias complicações. O objetivo deste estudo foi avaliar se o rastreio da DRD está sendo realizado de maneira adequada em pacientes com diabetes mellitus tipo 2 (DM2) atendidos na atenção primária à saúde (APS) do Sistema Único de Saúde. Foi realizado um estudo transversal, com duração de cinco meses, na APS dos municípios de Bernardino de Campos e Salto Grande, SP. Os critérios de inclusão foram: diagnóstico de DM2, idade > 18 anos, e ser acompanhado nas unidades participantes do estudo. Um total de 1093 atenderam aos critérios de inclusão e aceitaram participar do estudo. Foi verificado que 398 (36,4%) dos pacientes nunca realizaram os exames de albumina urinária e creatinina, e não tiveram calculados a relação albumina/creatinina em amostra de urina com o cálculo da taxa de filtração glomerular (TFG) estimada pela CKD-EPI a partir da creatinina sérica; 401 (36,7%) dos pacientes realizaram estes exames e tiveram estes índices calculados nos últimos 12 meses. Estes 401 pacientes realizaram estes exames e cálculos de rastreio da DRD uma vez a cada 12 meses nos últimos 5 anos. Os demais pacientes (294; 26,9%) realizaram somente exame de creatinina sérica nos últimos 12 meses. Os resultados demonstraram que o rastreamento da DRD não está sendo realizado de maneira adequada na maioria dos pacientes (AU).

Diabetes Kidney Disease (DRD) is asymptomatic in the early stages of the disease, and for this reason, most patients are diagnosed only when they already have several complications. The aim of this study was to assess whether DRD screening is being carried out properly in patients with type 2 diabetes mellitus (DM2) treated in primary health care (PHC) of the Unified Health System. A cross-sectional study was carried out, lasting five months, in the PHC of the municipalities of Bernardino de Campos and Salto Grande, SP. Inclusion criteria were: diagnosis of DM2, age > 18 years, and being monitored in the units participating in the study. A total of 1093 met the inclusion criteria and agreed to participate in the study. It was found that 398 (36.4%) of the patients had never performed urine albumin and creatinine tests, and they did not calculate the albumin/creatinine ratio in a urine sample, together with the calculation of the glomerular filtration rate (GFR) estimated by CKD-EPI from serum creatinine; in contrast, 401 (36.7%) of the patients underwent these exams and had these indexes calculated in the last 12 months. These 401 patients had these DRD screening tests and calculations performed once every 12 months for the last 5 years. Os demais pacientes (294; 26,9%) realizaram somente exame de creatinina sérica nos últimos 12 meses. Os resultados demonstraram que o rastreamento da DRD não está sendo realizado de maneira adequada na maioria dos pacientes (AU).

Frecuencia de enfermedad periodontal en pacientes adultos con diabetes mellitus tipo 2 en la Ciudad Autónoma de Buenos Aires y la Provincia de Buenos Aires / Frequency of periodontal disease in adult patients with type 2 diabetes mellitus in the Autonomous city of Buenos Aires and the province of Buenos Aires

Introducción: la enfermedad periodontal (EP) es un factor de riesgo en la génesis y evolución de numerosas enfermedades crónicas sistémicas como la diabetes mellitus (DM). Ambas comparten una evolución compleja y constituyen una relación bidireccional. Objetivos: describir la frecuencia de EP en pacientes adultos con diagnóstico de DM2, así como su gravedad y extensión al momento del diagnóstico inicial, su correlación con variables metabólicas y signos de complicación. Materiales y métodos: estudio transversal. Se recolectaron 626 historias clínicas de pacientes adultos con DM2 en la Ciudad Autónoma de Buenos Aires (CABA) y la Provincia de Buenos Aires. Resultados: la frecuencia de EP para la muestra (n=614) fue del 98% (gingivitis y periodontitis), la relación hombres y mujeres fue de 53/47% respectivamente, y la edad media 57,7±10,4 años. El análisis entre la derivación tardía, los años de antigüedad de la DM y la gravedad no resultaron significativos (p=0,49; p=0,7). Se observó correlación positiva con el mal control metabólico tanto para HbA1c (p=0,02) como para las glucemias en ayunas, y la relación microalbuminuria/creatininuria (p=0,0001). Se encontró relación entre las categorías de cobertura de salud, y la gravedad y extensión de la EP (p=0,0001). Los pacientes sin cobertura de salud presentaron cuadros más severos. Conclusiones: la frecuencia de EP fue altamente significativa en pacientes con DM2. Se evidenció correlación directa y significativa para la HbA1c y la microalbuminuria con respecto a la gravedad y la extensión de la EP, asociada con alteraciones microangiopáticas. Se requieren nuevos estudios sobre el análisis de marcadores metabólicos, de complicación micro y macrovascular en asociación con la EP

Introduction: periodontal disease (PD) is a risk factor in the genesis and evolution of numerous chronic systemic diseases, such as diabetes. Both share a complex evolution constituting a bidirectional relationship. Objectives: to describe the frequency of PD in adult patients diagnosed with type 2 diabetes (T2D), as well as its severity and extension at the time of initial diagnosis, its correlation with metabolic variables and signs of complications. Materials and methods: cross-sectional study; 626 medical records of adult patients with T2D in Autonomous city of Buenos Aires and the province of Buenos Aires. Results: the frequency of PD for the sample (n=614) was 98% (gingivitis and periodontitis), the relationship between men and women was 53/47%, respectively, mean age 57.7±10.4 years. The analysis between late referral, years of diabetes and severity were not significant (p=0.49; p=0.7). A positive correlation was observed with poor metabolic control for both HbA1c (p=0.02) and fasting glycemia, and the microalbuminuria/creatininuria ratio (p=0.0001). A relationship was found between health coverage categories, severity, and extension of PD (p=0.0001). Patients without health coverage presented more severe conditions. Conclusions: the frequency of PD is highly significant in patients with T2D. A direct and significant correlation was found for HbA1c and microalbuminuria with respect to the severity and extension of PD, associated with microangiopathic alterations. New studies are needed on the analysis of metabolic markers of micro and macro vascular complications in association with periodontal disease

Avaliação do consumo de frutas em pacientes com diabetes mellitus tipo 2 / Fruit consumption in patients with type 2 diabetes mellitus

Introdução: O impacto do consumo de frutas sobre a saúde de pacientes com diabetes mellitus tipo 2 (DM2) requer investigações. O objetivo deste estudo foi avaliar o consumo de frutas em pacientes com DM2 e identificar a sua associação com parâmetros de controle glicêmico.Métodos: Foram incluídos 197 pacientes ambulatoriais com DM2, submetidos à avaliação clínica, sociodemográfica, antropométrica, laboratorial e de consumo alimentar. A ingestão alimentar total e o consumo de frutas foram avaliados por questionário quantitativo de frequência alimentar. Os pacientes com menor e maior consumo de frutas (de acordo com a mediana) foram comparados.Resultados: A média do consumo de frutas foi de 593,66 ± 330,74 g/dia. Entre os menores e maiores consumidores de frutas, os valores de glicemia (169,42 ± 70,83 vs. 158,62 ± 64,56 mg/dL; p = 0,273) e hemoglobina glicada (8,39 ± 1,68 vs. 8,68 ± 2,38%; p = 0,319) não foram diferentes, assim como as demais variáveis. Os pacientes com maior consumo de frutas apresentaram maior ingestão de energia (p < 0,001), carboidratos (p < 0,001) e fibras (p = 0,006) e uma menor ingestão de proteínas (p = 0,015), lipídeos totais (p = 0,040) e seus tipos. O grupo que mais consumiu frutas apresentou uma maior ingestão de vitamina C (p < 0,001) e potássio (p < 0,001) e um menor consumo de sódio (p = 0,001). Foi observado ainda uma correlação negativa entre o consumo de frutas e o índice glicêmico da dieta (p = 0,05).Conclusão: Não houve diferença na glicemia em jejum e no valor de hemoglobina glicada entre os pacientes com DM2 com maior e menor consumo de frutas.

Introduction: The impact of fruit consumption on the health of patients with type 2 diabetes mellitus (T2DM) warrants investigation. The aim of this study was to evaluate fruit consumption in patients with T2DM and to identify its association with glycemic control parameters.Methods: We included 197 outpatients with T2DM who underwent clinical, sociodemographic, anthropometric, laboratory, and food consumption assessments. A food frequency questionnaire was used to assess total food intake and fruit consumption. Patients with lower and higher fruit consumption (according to the median) were compared.Results: Average fruit consumption was 593.66 ± 330.74 g/day. Blood glucose (169.42 ± 70.83 vs. 158.62 ± 64.56 mg/dL; p = 0.273) and glycated hemoglobin (8.39 ± 1.68% vs. 8.68 ± 2.38%; p = 0.319) levels did not differ between the lower and higher fruit consumption groups, nor did the other variables. Patients with higher fruit consumption had a higher intake of energy (p < 0.001), carbohydrates (p < 0.001), and fibers (p = 0.006) but a lower intake of proteins (p = 0.015) and total and different types of lipids (p = 0.040). The higher consumption group had higher vitamin C (p < 0.001) and potassium (p < 0.001) intake and lower sodium intake (p = 0.001). We identified a negative correlation between fruit consumption and the diet's glycemic index (p = 0.05).Conclusion: Fasting blood glucose and glycated hemoglobin levels did not differ between the higher and lower fruit consumption groups.

Frequência e fatores associados à dislipidemia entre pessoas com diabetes mellitus tipo 2 / Frequency and factors associated with dyslipidemia among people with type 2 diabetes mellitus / Frecuencia y factores asociados con la dislipidemia entre las personas con diabetes mellitus tipo 2

Objetivo: avaliar a frequência e os fatores associados à dislipidemia em pessoas com Diabetes Mellitus Tipo 2. Método: estudo transversal, desenvolvido com 45 pessoas diagnosticadas com diabetes e acompanhadas por uma Unidade Básica de Saúde. Foram investigadas variáveis sociodemográficas, relacionadas ao estilo de vida e referentes à análise do perfil lipídico. Resultados: a prevalência de dislipidemia foi de 82,2%, significativamente associada ao sexo feminino (p=0,005), ao tabagismo (p=0,002) e ao sedentarismo (p=0,050). Nos componentes da dislipidemia, as taxas de colesterol total, triglicérides e LDL se mostraram elevados em 68,9%, 57,8%, 11,1%, respectivamente. Já a taxa de HDL se mostrou diminuída em 2,2% dos investigados. Conclusão: a prevalência de dislipidemia mostrou-se elevada nos pacientes analisados. A existência de associação significativa entre a ocorrência de dislipidemia e variáveis como o sexo feminino, os hábitos de tabagismo e sedentarismo chama a atenção para a necessidade de melhores condutas para essa população

Objective: to evaluate the frequency and factors associated with dyslipidemia in people with type 2 Diabetes Mellitus. Method: cross-sectional study, carried out with 45 people diagnosed with diabetes and followed up at a Basic Health Unit. Sociodemographic variables related to lifestyle and related to lipid profile analysis were investigated. Results: the prevalence of dyslipidemia was 82.2%, significantly associated with female gender (p = 0.005), smoking (p = 0.002) and sedentary lifestyle (p = 0.050). The components of dyslipidemia, total cholesterol, triglycerides and low-density lipoproteins were elevated in 68.9%, 57.8% and 11.1%, respectively. Conclusion: the prevalence of dyslipidemia was high in the patients analyzed. The existence of a significant association between the occurrence of dyslipidemia and different types of females, smoking habits and sedentary lifestyle calls attention to the need for better conduct for this population

Objetivo: evaluar la frecuencia y los factores asociados a la dislipidemia en personas con Diabetes Mellitus tipo 2. Método: estudio transversal, desarrollado con 45 personas diagnosticadas con diabetes y acompañadas por una Unidad Básica de Salud. Se investigaron las variables sociodemográficas, de estilo de vida y de análisis del perfil lipídico. Resultados: la prevalencia de dislipidemia fue del 82,2%, asociada significativamente al sexo femenino (p=0,005), al tabaquismo (p=0,002) y al sedentarismo (p=0,050). En los componentes de la dislipidemia, las tasas de colesterol total, triglicéridos y lipoproteínas de baja densidad estaban elevadas en el 68,9%, 57,8% y 11,1%, respectivamente. Conclusión: la prevalencia de la dislipidemia fue elevada en los pacientes analizados. La existencia de una asociación significativa entre la ocurrencia de dislipidemia y variables como el sexo femenino, los hábitos de tabaquismo y el sedentarismo hace que se preste atención a la necesidad de mejores conductas para esta población

Profile of pharmaceutical interventions of a pharmacotherapeutic follow-up model for diabetic patients in a community pharmacy

Abstract The insertion of Pharmaceutical Care in Primary Health Care (PHC) improves patients' clinical outcomes and quality of life. Pharmacotherapeutic follow-up can contribute to the management of chronic diseases such as diabetes, promoting better glycemic control and adherence to therapy. This study aimed to assess the Drug-therapy Problems (DTPs) and Pharmacist Interventions (PIs) on the pharmacotherapeutic management in patients with type 2 diabetes mellitus (T2DM) in a community pharmacy. A quantitative, retrospective, and cross-sectional study was conducted in a Pharmaceutical Care Program within the PHC in Juiz de Fora (Minas Gerais, Brazil). Inclusion criteria were patients with T2DM above 18, who attended at least three pharmaceutical consultations between July 2016 and October 2018 and presented two or more glycated hemoglobin tests. The study group (n = 17) was largely composed of women (65%), elderly (76%), sedentary (72%), and obese people (52%). The resolution was achieved in 79% of the DTPs identified (n = 115). Most of DTPs were related to administration and adherence to pharmacotherapy (46%). 60% of the 437 PIs involved the provision of information and counseling. In other words, accessible interventions lead to high resolvability. Therefore, clinical actuation of pharmacists could improve the prognosis in diabetes treatment

Factores de riesgo asociados a diabetes mellitus tipo 2. Policlínico Docente José Jacinto Milanés. Matanzas, 2019 / Risk factors associated with type 2 diabetes mellitus. Teaching Polyclinic José Jacinto Milanés. Matanzas, 2019

RESUMEN Introducción: la diabetes es un trastorno endocrino-metabólico crónico que afecta a diversos órganos y tejidos. Más del 90 % de los que la padecen sufren diabetes tipo 2. Esta se acompaña de complicaciones crónicas, que pueden prevenirse mediante un control adecuado de la hiperglucemia y de los factores de riesgo cardiovascular. Objetivo: caracterizar los factores de riesgo asociados a la diabetes mellitus tipo 2, en pacientes del Consultorio del Médico de la Familia no. 27 del Policlínico Docente José Jacinto Milanés, del municipio Matanzas. Materiales y métodos: se realizó un estudio descriptivo de corte transversal, durante el período de enero a diciembre de 2019. El universo estuvo constituido por 50 pacientes pertenecientes al consultorio no. 27 del Policlínico Docente José Jacinto Milanés, del municipio Matanzas, dispensarizados con diabetes mellitus tipo 2. Resultados: el sexo femenino fue el predominante, y el 24 % de los pacientes se encontraban entre 55 y 59 años. En cuanto al estado nutricional, resultó la obesidad el de mayor frecuencia. En el 52 % existían antecedentes familiares de diabetes tipo 2. Conclusiones: la obesidad, los malos hábitos dietéticos, el sedentarismo y la hipertensión arterial constituyeron los factores de riesgo más frecuentes en estos pacientes (AU).

ABSTRACT Introduction: diabetes is a chronic endocrine-metabolic disorder that affects numerous organs and tissues. More than 90 % of those with it suffer from type 2 diabetes. This is accompanied by chronic complications, which can be prevented by adequate control of hyperglycemia and cardiovascular risk factors. Objective: to characterize the risk factors associated with type 2 diabetes mellitus in patients from the Family Physician's Office no. 27 of the Teaching Polyclinic José Jacinto Milanés, of the municipality of Matanzas. Materials and methods: a cross-sectional, descriptive study was carried out during the period from January to December 2019. The universe were 50 patients belonging to Family Physician's Office no. 27 of the Teaching Polyclinic José Jacinto Milanés, of the municipality of Matanzas, diagnosed with type 2 diabetes mellitus. Results: female sex predominated, and 24 % of patients were aged 55-59 years. According to the nutritional status, obesity was the more frequent. There was a family history of type 2 diabetes mellitus in 52 %. Conclusion: obesity, poor dietary habits, sedentary way of life, and arterial hypertension were the most frequent risk factors found in these patients (AU).

Frecuencia y factores asociados a la inercia tera¬péutica en inicio de insulinización en pacientes con Diabetes Mellitus II en el Hospital José Carrasco Arteaga, Cuenca, 2018 / Frequency and associated factors with therapeutic inertia at the start of insulin therapy in patients with Diabetes Mellitus II, Hospital José Carrasco Arteaga. Cuenca, 2018

INTRODUCCIÓN: La Diabetes Mellitus II es un problema sanitario a nivel mundial, sin excepción en nuestro país. El tratamiento farmacológico de la DM2 se basa en un esquema escalonado, que varía según las necesidades del paciente y el desarrollo de la enfermedad, así como del control glucémico del mismo. El retraso en la intensificación del tratamiento o el inicio de la insulinización, hecho que se conoce como inercia terapéutica, obedece a diferentes factores atribuibles tanto al paciente, como al sistema sanitario, aumentando el riesgo de complicaciones crónicas, tanto micro como macrovasculares. MATERIALES Y MÉTODOS: Se realizó un estudio observacional, transversal, descriptivo y de correlación. Se estudiaron 422 pacientes de consulta externa de Endocrinología y Medicina Interna del Hospital "José Carrasco Arteaga" en el año 2018, con diagnóstico de Diabetes Mellitus II que recibieron como tratamiento dos antidiabéticos orales; con el objetivo de conocer la frecuencia y factores asociados a la inercia terapéutica en estos pacientes. La recolección de datos se realizó a partir de las historias clínicas de los pacientes, en un formulario diseñado para el estudio. El análisis fue hecho en el programa SPSS v.25, aplicando estadística descriptiva y de correlación con la prueba Chi-cuadrado, con un nivel de confianza del 95%. RESULTADOS: El 59.2% de la muestra estudiada tenía 65 años o más, 54.7% fueron mujeres, 46.7% tenía sobrepeso y 36% obesidad. El 96.7% tenía tres o más años de evolución de la enfermedad, 63.7% presentaron control glucémico adecuado. La comorbilidad más frecuente fue la hipertensión arterial, que se presentó en el 61.6%. El 87% tenía Metformina más Glibenclamida como tratamiento. El 86.3% se encontraban recibiendo su actual tratamiento por más de tres meses. La inercia terapéutica se presentó en el 25.8%, y de estos casos, la inercia se relacionó con el personal de salud en el 75.2%. CONCLUSIÓN: Se presentó inercia terapéutica en el 25.8% de la muestra. La mayoría de las inercias terapéuticas están relacionadas con el personal de salud. No se encontró asociación estadísticamente significativa de la ocurrencia de la inercia terapéutica con la edad, el sexo, el nivel de instrucción, las comorbilidades, el estado nutricional o el tiempo de evolución de la DMII.(au)

BACKGROUND: Diabetes Mellitus II is a global health issue, with no exception in Ecuador. The pharmacological treatment of DM2 is based on a stepped scheme, which varies according to the patients' needs, the disease course, and the glycaemic control. The delay in the treatment intensification or the insulin initiation, known as therapeutic inertia, is caused by different factors attributable to both the patient and the health care systems, increasing the risk of both micro and macrovascular chronic complications. METHODS: we carried out an observational, cross-sectional, descriptive and correlation study. 422 patients from the Endocrinology and Internal Medicine outpatient clinic of "Hospital José Carrasco Arteaga" in 2018, with DM2 diagnosis, who received two oral antidiabetic drugs as treatment were studied; with the purpose of identifying the frequency and associated factors with therapeutic inertia in these patients. Data was collected from medical records in a form designed for this study. The data analysis was made in the SPSS v.25 software, applying descriptive statistics and correlation statistics with Chi-square test, with a confidence level of 95%. RESULTS: 59.2% of the sample was 65 years or older, 54.7% were women, 46.7% were overweight and 36% were obese. 96.7% had three or more years of diagnosis of the disease, 63.7% had adequate glycaemic control. The most frequent comorbidity was hypertension, which occurred in 61.6% patients. 87% were using Metformin plus Glibenclamide as treatment. 86.3% were receiving their current treatment for more than three months. Therapeutic inertia presented in 25.8% of the sample, and of these cases, inertia was related to health personnel in 75.2%. CONCLUSION: therapeutic inertia presented in 25.8% of the sample. Most of the therapeutic inertias were related to the health personnel. No significant statistically association was found between the occurrence of therapeutic inertia with age, sex, educational level, comorbidities, nutritional status or years of evolution of DMII.(au)

Evaluación de la prescripción de hipoglucemiantes orales en población adulta con Diabetes Mellitus Tipo 2 / Evaluation of the prescription of oral hypoglycemic agents in the adult population with type 2 diabetes mellitus

En el nivel primario de atención se detectan errores en la prescripción del tratamiento farmacológico de la diabetes tipo 2. El objetivo de este estudio fue evaluar la calidad de la prescripción de hipoglucemiantes orales en pacientes atendidos en consultorios del médico de la familia del Policlínico Universitario Hermanos Cruz, municipio Pinar del Río, Cuba. Se realizó un estudio de utilización de medicamentos de tipo descriptivo y transversal clasificado dentro de estos como de indicación-prescripción con elementos de esquema terapéutico y de factores que condicionan los hábitos de prescripción. El universo estuvo conformado por 1575 pacientes con diagnóstico de diabetes mellitus tipo 2 tratados con hipoglucemiantes orales que pertenecían a los 20 consultorios médicos de la familia.La muestra de estudio se obtuvo por el método de muestreo no probabilístico (por conveniencia) (n=846). La información se obtuvo de la historia clínica y tarjeta control de los pacientes para adquirir estos medicamentos. Predominó la edad de 40-49 años, el sexo femenino y entre 5-10 años de evolución de la enfermedad. No se usó la primera línea de tratamiento en el 43,6 % de los casos, ningún caso tenía estudios de laboratorio para el uso de la Metformina. La prescripción y dosis fue adecuada no así su uso racional. Las interacciones más frecuentes fueron las farmacocinéticas.El uso racional de hipoglucemiantes orales fue deficiente lo que hace necesario ampliar la divulgación de un protocolo de tratamiento para mejorar el uso de estos fármacos en el nivel primario de atención.

Errors in the prescription of drug treatment for type 2 diabetes are detected at the primary level of care. the purpose of this study was to evaluate the quality of the prescription of oral hypoglycemic agents in patients attended in the family doctor's offices of the Hermanos Cruz University Polyclinic, Pinar del Río distrit, Cuba. A descriptive and cross-sectional study of the use of medications was carried out, classified within these as indication-prescription with elements of the therapeutic scheme and factors that condition prescription habits. The universe was made up of 1575 patients diagnosed with type 2 diabetes mellitus treated with oral hypoglycemic agents who belonged to the 20 family medical offices. The study sample was carried out by the non-probabilistic sampling method (for convenience) (n = 846). The information was obtained from the clinical history and control card of the patients to acquire these medications. The age of 40-49 years, the female sex and between 5-10 years of evolution of the disease predominated. The first line of treatment was not used in 43.6% of the cases; no case had laboratory studies for the use of Metformin. The prescription and dose was adequate, but not its rational use. The most frequent interactions were pharmacokinetic ones.The rational use of oral hypoglycemic agents was deficient, which makes it necessary to expand the dissemination of a treatment protocol to improve the use of these drugs at the primary level of care.

Effect of lifestyle intervention holistic approach on blood glucose levels, health-related quality of life and medical treatment cost in type 2 diabetes mellitus patients

Type 2 Diabetes Mellitus (T2DM) is a costly, lifestyle-related disorder, its management is very critical and challenging hence lifestyle intervention may a cornerstone in the reversal and management of T2DM. This study designed to assess the impact of lifestyle intervention holistic (LIH) Model on blood glucose levels (BGL), Health-Related Quality of Life (HRQOL), and medical treatment cost in T2DM patients. This prospective, quasi-experimental study was conducted among 224 T2DM patients in Delhi Diabetes Research Center (DDRC), New Delhi. The study participants were allocated into two groups-Lifestyle Intervention Counseling (LIC) group received lifestyle-based counseling through the LIH model while the Usual-care group received only standard treatment. Study outcomes were assessed at baseline, 3rd, 6th, and 12th month and data were analyzed through SPSS. Study results revealed that LIC participants had decreased in fasting blood glucose 0.26 mg dL-1(-4.37 to 4.89), blood glucose postprandial -70.16 mg dL-1(-85.15 to -55.16), HbA1C -2.82% (-5.26 to -0.37), medicine cost (p < 0.004), hospitalization cost (p < 0.011), and cost of surgery (p < 0.0005). A significant improvement also observed in HRQOL and adherence towards a holistic model in LIC group. The study concludes that lifestyle-based counseling and its adherence was cost-effective and significantly improves BGL, HRQoL, and medical treatment in T2DM patients.

Evaluation of galectin-3 levels in patients with type 2 diabetes mellitus and chronic kidney disease / Avaliação dos níveis de galectina-3 em pacientes com diabetes mellitus tipo 2 e doença renal crônica

ABSTRACT INTRODUCTION: Type 2 diabetes mellitus (T2DM) is the most common manifestation of diabetes, accounting for about 90% of diagnosed cases. The causes of T2DM are not fully understood, but its pathogenesis is possibly associated with increased adiposity and a chronic low-grade inflammatory response. The glycoprotein galectin-3 (Gal-3) is known to play an important role in the modulation of blood glucose, adiposity, and inflammation. OBJECTIVES: The aim of this study was to evaluate Gal-3 levels in patients with T2DM and chronic kidney disease (CKD), in addition to relating them with complications and comorbidities present in these patients, comparing them to a control group. MATERIAL AND METHODS: Gal-3 was evaluated in 84 selected individuals, of which 42 had clinical and laboratory diagnosis of T2DM and CKD (treated at Santa Casa Hospital in Belo Horizonte, Minas Gerais, Brazil), and 42 individuals from the local community, with no history of diabetes (control group). RESULTS AND DISCURSION: Gal-3 levels were significantly higher (p = 0.012) in the T2DM group (15.17 ± 5.54 ng/ml) when compared to the control group (12.62 ± 3.2 ng/ml). There was a tendency for higher levels of Gal-3 in diabetic patients with hypertension (15.74 ± 5.61 ng/ml) when compared to patients without this complication (10.96 ± 2.49 ng/ml) (p = 0.069) CONCLUSION: The results suggest that Gal-3 may be involved in the pathophysiology of T2DM and still be a promising biomarker associated with hypertension in this group.

RESUMEN INTRODUCCIÓN: La diabetes mellitus tipo 2 (DM2) es la forma más común de la diabetes; representa alrededor del 90% de los casos diagnosticados. Todavía no se conocen por completo las causas de la DM2, pero posiblemente su etiopatogénesis se relaciona con el aumento de adiposidad y una respuesta inflamatoria crónica de bajo grado. Se sabe que la glicoproteína galectina 3 (Gal-3) juega un papel importante en la modulación de glucemia, adiposidad e inflamación. OBJETIVOS: Evaluar los niveles de Gal-3 en pacientes con DM2 y enfermedad renal crónica, además de relacionarlos con las otras complicaciones y comorbilidades presentes en eses individuos, comparándolos con un grupo control. MATERIAL Y MÉTODO: La Gal-3 fue evaluada en 84 pacientes elegidos; entre esos, 42 poseían el diagnóstico clínico y de laboratorio de DM2 y enfermedad renal crónica (atendidos en el Hospital Santa Casa de Belo Horizonte, Minas Gerais, Brasil) y 42 eran de la comunidad local, sin historial de diabetes (grupo control). RESULTADOS Y DISCUSIÓN: Los niveles de Gal-3 fueron más altos (p = 0,012) en el grupo con DM2 (15,17 ± 5,54 ng/ml) que en el grupo control (12,62 ± 3,2 ng/ml). Hubo tendencia de mayores niveles de Gal-3 en los pacientes diabéticos con hipertensión (15,74 ± 5,61 ng/ml) que en aquellos sin esa complicación (10,96 ± 2,49 ng/ml) (p = 0,069). CONCLUSIÓN: Los resultados obtenidos apuntan que la Gal-3 puede estar involucrada en la etiología de la DM2 y aún ser un biomarcador prometedor de hipertensión en ese grupo.

RESUMO INTRODUÇÃO: O diabetes mellitus tipo 2 (DM2) é a manifestação mais comum do diabetes; representa cerca de 90% dos casos diagnosticados. As causas do DM2 ainda não foram completamente estabelecidas, mas sua patogênese está, possivelmente, relacionada com o aumento da adiposidade e uma resposta inflamatória crônica de baixo grau. Sabe-se que a glicoproteína galectina-3 (Gal-3) possui papel importante na modulação de glicemia, adiposidade e inflamação. OBJETIVOS: Avaliar os níveis de Gal-3 em pacientes com DM2 e doença renal crônica, além de relacioná-los com as demais complicações e comorbidades presentes nesses indivíduos, comparando-os com um grupo-controle. MATERIAL E MÉTODOS:: A Gal-3 foi avaliada em 84 pacientes selecionados; destes, 42 possuíam o diagnóstico clínico e laboratorial de DM2 e doença renal crônica (atendidos no Hospital Santa Casa de Belo Horizonte, Minas Gerais, Brasil), e 42 eram da comunidade local, sem histórico de diabetes (grupo-controle). RESULTADOS E DISCUSSÃO: Os níveis de Gal-3 foram significativamente mais elevados (p = 0,012) no grupo com DM2 (15,17 ± 5,54 ng/ml) quando comparados com os níveis do grupo-controle (12,62 ± 3,2 ng/ml). Houve tendência em maiores níveis de Gal-3 nos pacientes diabéticos com hipertensão (15,74 ± 5,61 ng/ml) em comparação com os pacientes sem essa complicação (10,96 ± 2,49 ng/ml) (p = 0,069). CONCLUSÃO: Os resultados obtidos sugerem que a Gal-3 pode estar envolvida na fisiopatologia do DM2 e ainda ser um promissor biomarcador associado à hipertensão nesse grupo.

Incidence and associated factors of type 2 diabetes mellitus onset in the Brazilian HIV/AIDS cohort study

ABSTRACT Background: People living with HIV (PLH) under combined antiretroviral therapy (cART) are at risk of developing type 2 diabetes mellitus (T2DM). Objective: We examined the incidence of T2DM, associated factors and mean time to outcome in PLH under cART. Method: Data for this multicenter cohort study were obtained from PLH aged over 18, who started cART in 13 Brazilian sites from 2003 to 2013. Factors associated with incident T2DM were evaluated by Cox multiple regression models. Results: A total of 6724 patients (30,997.93 person-years) were followed from January 2003 to December 2016. A T2DM incidence rate of 17.3/1000 person-years (95%CI 15.8-18.8) was observed. Incidence of isolated hypertriglyceridemia and impaired fasting glucose (IFG) were 84.3 (95%CI 81.1-87.6) and 14.5/1000 person-years (95%CI 13.2-15.9), respectively. Mean time to T2DM onset was 10.5 years (95%CI 10.3-10.6). Variables associated with incident T2DM were age 40-50 [Hazard Ratio (HR) 1.7, 95%CI 1.4-2.1] and ≥ 50 years (HR 2.4, 95%CI 1.9-3.1); obesity (HR 2.1, 95%CI 1.6-2.8); abnormal triglyceride/HDL-cholesterol ratio (HR 1.8, 95%CI 1.51-2.2). IFG predicted T2DM (HR 2.6, 95%CI 1.7-2.5) and occurred on average 3.3 years before diabetes onset. Exposure to stavudine for ≥ 2 years was independently associated with incident T2DM [HR 1.6, 95%CI 1.0-2.2). Conclusion: Brazilian PLH under cART are at significant risk of developing T2DM and share risk factors for diabetes onset with the general population, such as older age, obesity, and having metabolic abnormalities at baseline. Moreover, stavudine use was independently associated with incident T2DM. Identifying PLH at a higher risk of T2DM can help caretakers trigger health promotion and establish specific targets for implementation of preventive measures.

Factores demográficos y clínicos que explican la progresión de la Enfermedad Renal Crónica en un programa de nefroprotección del departamento de Nariño, Colombia 2016-2018 / Demographic and clinical factors that explain the progression of Chronic Kidney Disease in a nephroprotection program in the department of Nariño, Colombia between 2016-2018

Resumen Introducción: La Enfermedad Renal Crónica es una patología de gran impacto en salud pública a nivel mundial, su progresión está determinada por limitaciones en el control de sus factores de riesgo y pronóstico. Los programas de nefroprotección hacen seguimiento y control de los pacientes con la enfermedad, intentando llevarlos a cumplir las metas específicas de nefroprotección para limitar la progresión de la Enfermedad Renal Crónica. Objetivo: Determinar los factores explicativos de la progresión de la Enfermedad Renal Crónica en pacientes atendidos en un programa de nefroprotección. Materiales y métodos: Estudio analítico observacional de cohorte retrospectivo en 5872 pacientes con Enfermedad Renal Crónica en diferentes estadios, participantes de un programa de nefroprotección en el departamento de Nariño durante el período 2016-2018. La progresión de la ERC, correspondió a la disminución de la Tasa de Filtración Glomerular en 5mL/min/1.73 m2 o más. La información se obtuvo de la base de datos del programa. Se construyó un modelo explicativo ajustado por variables demográficas y clínicas. Acorde al diseño se utilizó un modelo binomial con función de enlace logarítmica para estimar los coeficientes de regresión de las variables de interés. Las medidas de asociación fueron los Riesgos Relativos. Resultados: el 72,2% fueron mujeres, el 75,1% tenían 60 años o más, el 12,4% eran afrocolombinos, y el 85% mestizos, se presentó progresión el 49,2% (IC 95% 47,9-50,4) de los casos. Los factores que mejor explicaron la relación la progresión de ERC, fueron: ser hombre con un RR ajustado de 1,04 (IC95%:1,00-1,15), y tener un estadio de la ERC, de 4, 5 y 3a-b, con RR ajustado 1,62 (IC1,36-1,94) y 1,41 (IC1,21-1,63) respectivamente. Conclusiones: En la población nariñense de Colombia afiliada a un programa de nefroprotección, la progresión de la ERC fue del 49,2%, siendo explicada de forma significativa por el sexo masculino, y los estadios avanzados de la enfermedad.

Abstract Introduction: Chronic Kidney Disease is a pathology of great impact on public health worldwide, its progression is determined by limitations in the control of its risk factors and prognosis. Nephroprotection programs monitor, control, and limit the progression of this disease in the patients while trying to lead them to meet the specific program goals. Objective: To determine the factors that boost the progression of Chronic Kidney Disease in patients treated in a nephroprotection program. Materials and methods: This retrospective analytical observational cohort study was carried out in 5872 patients from a nephroprotection program with different stages of Chronic Kidney Disease, in the department of Nariño between 2016 and 2018. The progression of CKD corresponded to a decrease in the Glomerular Filtration Rate by 5mL / min / 1.73 m2 or more; this information was obtained from the program's database. An explanatory model was built and adjusted taking into consideration demographic and clinical variables. According to the design, a binomial model with a logarithmic link function was used to estimate the regression coefficients of the variables of interest. The association measures were the Relative risks. Results: In the final results it was found that 72.2% were women, 75.1% were 60 years old or older, 12.4% were afro-colombian, 85% were mixed race, and 49.2% presented progression (95% CI 47 , 9-50.4) of the cases. The factors that best explained the relationship between CKD progression were: being a man with an adjusted RR of 1.04 (95% CI: 1.00-1.15), and having a CKD stage of 4, 5 and 3a-b, with adjusted RR 1.62 (CI1.36-1.94) and 1.41 (CI1.21-1.63) respectively. Conclusions: In the Nariño population of Colombia that is affiliated to a nephroprotection program the progression of CKD was 49.2% according to the male sex and the advanced stages of the condition.

Prevalencia de la enfermedad renal crónica en pacientes con diabetes mellitus tipo 2 de un programa de riesgo cardiovascular / Prevalence of chronic kidney disease in a population with type 2 diabetes of a cardiovascular risk program

Resumen Introducción: la diabetes mellitus tipo 2 (DM2) es la principal causa de nefropatía terminal en el mundo. Se sabe que en Colombia esta enfermedad tiene una prevalencia del 7-9 %, pero para algunos municipios no hay datos sobre el número de personan que padecen DM2 y enfermedad renal crónica (ERC), ni sobre los factores de riesgo relacionados con su desarrollo. Objetivo: determinar la prevalencia y los factores de riesgo para desarrollar ERC en una población de pacientes con DM2 que consultaron a un programa de riesgo cardiovascular de una institución de salud de Armenia, Colombia, durante el año 2017. Materiales y métodos: estudio descriptivo de corte transversal realizado en una muestra de 232 pacientes. Se describieron las variables con medidas de tendencia central e intervalos de confianza del 95 %, se realizó análisis de varianza y pruebas Chi cuadrado para las variables numéricas y categóricas, respectivamente; se aplicaron los modelos de regresión múltiple y regresión logística, y se consideró una diferencia estadísticamente significativa con un valor de p<0,05. Resultados: la prevalencia de DM2 fue del 34,14 % y la de ERC varió entre 22,41 % y 38,79 %, según la ecuación utilizada. El 69,83 % de la población se encontró en normoalbuminuria; el 25 %, en microalbuminuria, y el 5,17 °%, en macroalbuminuria. Los factores de riesgo identificados para ERC fueron edad (Cockcroft-Gault y CKD-EPI p<0,001; MDRD p=0,012), perímetro abdominal (Cockcroft-Gault p<0,001; MDRD p=0,028; CKD-EPI p=0,011), nivel de creatinina (Cockcroft-Gault, MDRD, CKD-EPI p<0,001) y sedentarismo (Cockcroft-Gault p=0,046). Las ecuaciones más adecuadas para identificar tempranamente la ERC en la población estudiada fueron CKD-EPI (R2=85,74 %) y Cockcroft-Gault (R2=85,43 %), con un valor de pronóstico de 95,68 % y 93,96 %, respectivamente. Conclusión: la prevalencia de ERC, que osciló entre 22,41 % y 38,79 %, dependió de la ecuación utilizada. Los factores de riesgo para desarrollar ERC fueron edad, nivel de creatinina, perímetro abdominal y sedentarismo. Se propone que para esta población las ecuaciones Cockcroft-Gault y CKD-EPI son las más adecuadas para identificar la ERC.

Abstract Introduction: In Colombia, the prevalence of type 2 diabetes mellitus (DM2) is 7-9%, this being the main cause of end-stage renal disease in the world4. In the municipality of Armenia, the prevalence of the population suffering from DM2 with chronic kidney disease (CKD) and the risk factors related to its development are unknown. Objective: To determine the prevalence and risk factors of developing chronic kidney disease (CKD) in a population with type 2 diabetes, consultants to a cardiovascular risk program of an IPS of Armenia, Colombia, during the year 2017. Methods: Descriptive cross-sectional study with 232 patients. The variables were described by measures of central tendency and 95 % confidence intervals, ANOVA and Chi square tests were performed for the numerical and categorical variables respectively, multiple regression and logistic regression, with a value of P <0.05. Results: The prevalence of diabetes was 34.14 % and CKD varies between 22.41-38.79 % according to the equation used. 69.83 % are in normoalbuminuria, 25 % in microalbuminuria and 5.17 % in macroalbuminuria. The risk factors identified for CKD were: age (Cockcroft-Gault and CKD-EPI p <0.001; MDRD p = 0.012), abdominal perimeter (Cockcroft-gault p <0.001; MDRD p = 0.028; CKD-EPI p = 0.011), creatinine level (Cockcroft-gault, MDRD, CKD-EPI p <0.001) and sedentary lifestyle (Cockcroft-gault p = 0.046). The most adequate equations for early identification of CKD in this population are CKD-EPI (R2 = 85.74 %) and Cockcroft-gault (R2 = 85.43 %), with a prognostic value of 95.68 % and 93, 96 % respectively. Conclusion: The prevalence of CKD varies between 22.41 % and 38.79 %, depending on the equation used. The risk factors for developing CKD are age, creatinine level, abdominal perimeter and sedentary lifestyle. It is proposed that for this population the Cockcroft-Gault and CKD-EPI equations are the most adequate to identify CKD.

Concordância na velocidade da marcha de mulheres diabéticas tipo 2 em diferentes testes de caminhada / Agreement in the gait speed of type 2 diabetic women from different walking tests

O objetivo desse estudo foi verificar a concordância na velocidade da marcha (VM) a partir dos testes de caminhada de seis minutos (6MWT) e de quatro metros (4MWT) em mulheres diabéticas tipo 2 (DM2). Os testes foram realizados antes e após intervenção de 12 semanas com exercícios físicos. O 4MWT foi realizado em espaço de quatro metros, sendo o resultado do teste medido como o tempo gasto (segundos) no percurso. O 6MWT foi realizado em modelo de ir e vir em uma distância de 15 metros e o resultado foi a distância total (metros) percorrida. Os resultados foram padronizados para velocidade de deslocamento (m/s). Para avaliar a concordância (6MWTpré x 4MWTpré) e (6MWTpósx 4MWTpós), utilizou-se o teste de Bland-Altman (B-A) e o coeficiente de concordância de correlação de Lin. O nível de significância aceito para o estudo foi α 5%. Foram medidas 39 mulheres, com idade média de 58,79 ± 10,03 anos e diagnóstico de DM2 a 8,64 ± 8,53 anos. Verificou-se, pelo teste de B-A, diferenças na VM dos testes de -0,001 ± 0,19 m/s (IC95%: -0,37 a 0,37 m/s) no início e 0,02 ± 0,21 m/s (IC95%: -0,39 a 0,42 m/s) ao final e concordância de 0,60 (IC95%: 0,41 a 0,79; p < 0,001) e 0,52 (IC95%: 0,31 a 0,73; p < 0,001) pré e pós, respectivamente, pelo coeficiente de concordância de correlação Lin. Através dos dados obtidos, sugere-se que os dois testes podem ser utilizados para avaliar a VM das mulheres DM2, porém o 6MWT apresentou maior reprodutibilidade para detectar mudanças na VM ao longo do tempo

This study aimed to test the agreement in the gait speed (GS) between the 6-minute walk test and the 4-me-ter gait speed (6MWT - 4MWT) in type 2 diabetic women (T2DM). The tests were performed before and after a 12-week physical exercise intervention. The 4MWT was performed in a space of four meters, with results based on the time spent (seconds) to complete a 4-meter distance. The 6MWT was carried out similar to a yo-yo test in 15 meters and the result was operationalized by the total distance (meters) covered. The results of the tests were standardized as speed (m/s). To evaluate agreements (6MWTbefore x 4MWTbefore) and (6MWTafter x 4MWTafter), Bland-Altman (B-A), and Lin's agreements were used. The level of significance was set at 5%. A total of 39 women were evaluated, mean age 58.79 ± 10.03 years, diagnosis of diabetes at 8.64 ± 8.53 years.The B-A test showed a mean difference in GS of -0.001 ± 0.19 m/s (95%CI: -0.37 to 0.37 m/s) before and 0.02 ± 0.21 m/s (95%CI: -0.39 to 0.42 m/s) after, and Lin's agreements of 0.60 (95%CI: 0.41 to 0.79; p < 0.001) and 0.52 (95%CI: 0.31 to 0.73; p < 0.001) before and after, respectively. Based on our data it is suggested that the two tests can be used to evaluate the GS of T2DM women, but the 6MWT was more reproductible to detect changes in GS over time

Problematization educational intervention to promote healthy habits in elderly people with diabetes: randomized clinical trial / Intervención educativa problematizadora para promover hábitos saludables en personas ancianas con diabetes: ensayo clínico aleatorizado / Intervenção educativa problematizadora para promoção de hábitos saudáveis em idosos com diabetes: ensaio clínico randomizado

ABSTRACT Objective: to assess the effects of a problematization educational intervention to promote healthy habits in elderly people with diabetes. Methods: a randomized clinical trial conducted with 202 individuals drawn for the intervention group and the control group. The intervention consisted of problematization educational activities on a monthly basis for over six months. The control group participated in conventional monitoring at the health unit. Data were collected through semi-structured interviews before and after the intervention, in addition to laboratory tests. Results: after the intervention, when compared to the control group, there was an increase in knowledge about the disease (p<0.001), positive attitude towards self-care (p=0.011), physical activity (p=0.020), diet variety (p=0.002), and lower consumption of oils and fats (p<0.05). Conclusion: the intervention performed has a beneficial effect to promote healthy habits.

RESUMEN Objetivo: evaluar los efectos de una intervención educativa problemática para la promoción de hábitos saludables en personas mayores con diabetes. Métodos: ensayo clínico aleatorizado, realizado con 202 individuos elegidos para dos grupos: intervención y control. La intervención consistió en problematizar las actividades educativas grupales, mensualmente, durante seis meses. El grupo de control participó en el monitoreo convencional en la unidad de salud. Los datos fueron recolectados a través de entrevistas semiestructuradas antes y después de la intervención, además de las pruebas de laboratorio. Resultados: después de la intervención, un aumento en el conocimiento sobre la enfermedad (p<0.001), una actitud positiva hacia el autocuidado (p=0.011), actividad física (p=0.020), variedad de dieta (p=0.002) y menor consumo de aceites y grasas (p<0.05), en comparación con el grupo de control. Conclusión: la intervención realizada tiene un efecto beneficioso para la promoción de hábitos saludables.

RESUMO Objetivo: avaliar os efeitos de uma intervenção educativa problematizadora para a promoção de hábitos saudáveis em idosos com diabetes. Métodos: ensaio clínico randomizado, realizado com 202 indivíduos sorteados para dois grupos: intervenção e controle. A intervenção consistiu em atividades educativas grupais problematizadoras, mensalmente, ao longo de seis meses. O grupo controle participou do acompanhamento convencional na unidade de saúde. Os dados foram coletados mediante entrevistas semiestruturadas antes e após a intervenção, além da realização de exames laboratoriais. Resultados: após a intervenção, foi evidenciado aumento do conhecimento sobre a doença (p<0,001), atitude positiva para o autocuidado (p=0,011), prática de atividade física (p=0,020), variedade da dieta (p=0,002) e menor consumo de óleos e gorduras (p<0,05), quando comparado ao grupo controle. Conclusão: a intervenção realizada tem efeito benéfico para a promoção de hábitos saudáveis.

Effectiveness of ginger in reducing metabolic levels in people with diabetes: a randomized clinical trial / Efetividade do gengibre na redução de níveis metabólicos de pessoas com diabetes: ensaio clínico randomizado / Eficacia del jengibre en la reducción de los niveles metabólicos de personas con diabetes: un ensayo clínico aleatorizado

Objective: to evaluate the effectiveness of ginge (Zingiber officinale) in reducing blood sugar and lipid levels in people with type 2 diabetes. Method: a randomized and double-blind clinical trial conducted with people with type 2 diabetes in primary care facilities. The study included individuals aged between 20 and 80 years old, using oral antidiabetic drugs and with HbA1c levels between 6.0% and 10%. The participants were paired 1:1, allocated in two distinct groups, and randomized in blocks, based on their HbA1c levels. In the experimental group, the participants used 1.2g of ginger and, in the control group, 1.2g of placebo, daily for 90 days. The primary outcome was a reduction in fasting blood sugar and HbA1c, and the secondary outcome was a reduction in lipids and HOMA-IR. 103 individuals completed the study, 47 in the experimental group and 56 in the control group. Results: the participants in the experimental group showed a greater reduction in the blood glucose and total cholesterol values compared to the control group. Conclusion: the use of ginger can help in the treatment of people with diabetes, and data support the inclusion of this herbal drug in the clinical practice of nurses. RBR-2rt2wy

Objetivo: avaliar a efetividade do gengibre (Zingiber officinale) na redução de níveis glicêmicos e lipídicos de pessoas com diabetes tipo 2. Método: ensaio clínico randomizado, duplo cego, conduzido com pessoas com diabetes tipo 2, em unidades de atenção primária à saúde. Foram incluídos no estudo indivíduos com idade entre 20 e 80 anos, em uso de antidiabéticos orais e com valores de HbA1c entre 6,0% e 10%. Os participantes foram pareados de 1:1, alocados em dois grupos distintos e randomizados em blocos, com base nos valores de HbA1c. No grupo experimental os participantes usaram 1,2g de gengibre, e no grupo controle 1,2g de placebo, diariamente, durante 90 dias. Os desfechos primários foram a redução da glicemia venosa de jejum e HbA1c, e os secundários a redução dos lipídicos e HOMA-IR. 103 pessoas concluíram o estudo, encontrando-se 47 no grupo experimental e 56 no grupo controle. Resultados: os participantes do grupo experimental apresentaram melhor redução dos valores de glicemia e colesterol total, em comparação com o grupo controle. Conclusão: o uso do gengibre pode auxiliar o tratamento das pessoas com a diabetes, e os dados dão suporte para a inserção desse fitoterápico na prática clínica dos enfermeiros. RBR-2rt2wy

Objetivo: evaluar la eficacia del jengibre (Zingiber officinale) en la reducción de los niveles glucémicos y de lípidos en personas con diabetes tipo 2. Método: ensayo clínico aleatorizado y doble ciego, realizado con personas con diabetes tipo 2 en unidades de atención primaria de salud. Se incluyeron en el estudio individuos con edades comprendidas entre 20 y 80 años, que utilizaban antidiabéticos orales y con valores de HbA1c entre 6,0% y 10%. Los participantes fueron comparados de forma equitativa (1:1), asignados a dos grupos distintos y aleatorizados en bloques, basados en sus valores de HbA1c. En el grupo experimental, los participantes utilizaron 1,2 g de jengibre, y en el grupo de control 1,2 g de placebo, diariamente durante 90 días. Los resultados primarios fueron la reducción de glucemia venosa en ayunas y de HbA1c, y los resultados secundarios fueron la reducción de lípidos y del índice HOMA-IR. El estudio contó con la participación de 103 personas, 47 en el grupo experimental y 56 en el grupo de control. Resultados: los participantes del grupo experimental presentaron una mayor reducción en los valores de glucosa y colesterol total, en comparación con el grupo de control Conclusión: el uso del jengibre puede ayudar en el tratamiento de personas con diabetes, y los datos respaldan la introducción de este fitoterapéutico en la práctica clínica de los enfermeros. RBR-2rt2wy

Self-efficacy in elderly with type 2 Diabetes Mellitus / Autoeficacia en ancianos con Diabetes Mellitus tipo 2 / Autoeficácia em idosos com Diabetes Mellitus tipo 2

ABSTRACT Objective: to analyze the self-efficacy of elderly with type 2 diabetes mellitus and the relationship with sociodemographic, clinical, knowledge, and attitude variables. Method: a cross-sectional quantitative study conducted with 256 elderly people enrolled in Family Health Strategies. Data were obtained through interviews. Descriptive statistical analysis and multiple linear regression model were performed (p <0.05). Results: female, 69.95-year mean age, white skin color, 4-7 years of schooling, living with a partner, retirees, low individual monthly income, 6 to 15 years of illness, Catholics, living with children (with or without spouse). The elderly's low knowledge and negative attitude prevailed. Self-efficacy was associated with attitude and knowledge in the domains "General and Specific Diet", "Physical Exercise" and "Blood Glucose". Conclusion: self-efficacy investigations in type 2 Diabetes Mellitus management in the elderly are important and encourage treatment adherence.

RESUMEN Objetivo: analizar la auto-eficacia de ancianos con Diabetes Mellitus tipo 2 y la relación con las variables socio-demográficas, clínicos, de conocimiento y actitud. Métodos: estudio transversal, cuantitativo, realizado con 256 ancianos, registrados en Estrategias Salud de la Familia. Los datos fueron obtenidos a través de entrevistas. Se realizó un análisis estadístico descriptivo y un modelo de regresión lineal múltiple (p <0,05). Resultados: se predominó sexo femenino, promedio medio 69,95 años, color de la piel blanca, 4 a 7 años de escolaridad, residentes con compañero, jubilados, baja renta mensual individual, de 6 a 15 años de enfermedad, católicos, viviendo con hijos (con o sin cónyuge). Conclusión: se destaca la importancia de investigaciones sobre la auto-eficacia en el manejo del Diabetes Mellitus tipo 2 en ancianos en el sentido de incentivar la adhesión al tratamiento.

RESUMO Objetivo: analisar a autoeficácia de idosos com Diabetes Mellitus tipo 2 e a relação com as variáveis sociodemográficas, clínicas, de conhecimento e atitude. Método: estudo transversal, quantitativo, realizado com 256 idosos cadastrados em Estratégias Saúde da Família. Obteve-se os dados através de entrevistas. Procedeu-se análise estatística descritiva e modelo de regressão linear múltipla (p<0,05). Resultados: predominou-se sexo feminino, idade média de 69,95 anos, cor da pele branca, 4 a 7 anos de escolaridade, residentes com companheiro, aposentados, baixa renda mensal individual, 6 a 15 anos de doença, católicos, morando com filhos (com ou sem cônjuge). Prevaleceu o baixo conhecimento e atitude negativa dos idosos. A autoeficácia associou-se à atitude e ao conhecimento nos domínios "Nutrição geral e específica", "Exercício físico" e "Glicose sanguínea". Conclusão: destaca-se a importância de investigações sobre a autoeficácia no manejo do Diabetes Mellitus tipo 2 em idosos no sentido de incentivar a adesão ao tratamento.

Exploratory spatial analysis of diabetes mortality and its relationship with the socioeconomic conditions of Colombian municipalities / Análisis espacial exploratorio de la mortalidad por diabetes y la relación con condiciones socioeconómicas en los municipios colombianos / Análise espacial exploratória da mortalidade por diabetes e a relação com condições socioeconômicas nos municípios colombianos

Type 2 diabetes mellitus prevalence has increased worldwide, especially in low- and middle-income countries. This study aimed to evaluate in the Colombian context whether the geographic variations of mortality due to type 2 diabetes mellitus are random or statistically significant and to measure the effect of the socioeconomic conditions of municipalities on these variations. An ecological study of trends for regions and subregions was undertaken considering two periods (2003-2009 and 2010-2016). The study population consisted of adults of 20 to 79 years old residing in each of Colombia's municipalities during the period 2003-2016. Smoothed and standardized mortality rates were obtained by fitting a hierarchical Bayesian model, which considers the spatial structure of the data. Four socioeconomic variables related to municipal deprivation and development were included into the model to obtain their relative risk (RR) and 95% credible intervals. Mortality due to type 2 diabetes mellitus decrease between 2003 and 2016 in Colombia, both nationally and regionally. In addition, there was a clear positive association between mortality due to diabetes mellitus and the level of municipal development; the wealthiest and most developed municipalities had higher mortality risks.

La prevalencia de la diabetes mellitus tipo 2 ha aumentado a nivel global, principalmente en los países de renta media y baja. El estudio tuvo como objetivo evaluar si en Colombia las variaciones geográficas de la mortalidad por diabetes mellitus tipo 2 son aleatorias o estadísticamente significativas, además de medir el efecto de las condiciones socioeconómicas de los municipios sobre esas variaciones. Se realizó un estudio ecológico de las tendencias en las regiones y sub-regiones, considerando dos períodos (2003-2009 y 2010-2016). La población del estudio incluía adultos entre 20 y 79 años de edad, residentes en cada municipio de Colombia, durante el período de 2003-2016. Las tasas de mortalidad suavizadas y estandarizadas se obtuvieron mediante un ajuste de un modelo bayesiano jerárquico, teniendo en cuenta la estructura espacial de los datos. Cuatro variables socioeconómicas relacionadas con la privación y el desarrollo municipal se incluyeron en el modelo para obtener el riesgo relativo (RR) e intervalos de credibilidad de 95%. La mortalidad por diabetes mellitus tipo 2 disminuyó entre 2003 y 2016 en Colombia, en los niveles tanto nacional, como regional. Asimismo, hubo una asociación positiva entre mortalidad por diabetes mellitus y nivel de desarrollo municipal; los municipios más ricos y más desarrollados presentaron un mayor riesgo de mortalidad.

A prevalência do diabetes mellitus tipo 2 tem aumentado em nível global, principalmente nos países de renda média e baixa. O estudo teve como objetivo avaliar se na Colômbia, as variações geográficas da mortalidade por diabetes mellitus tipo 2 são aleatórias ou estatisticamente significativas, além de medir o efeito das condições socioeconômicas dos municípios sobre essas variações. Foi realizado um estudo ecológico das tendências nas regiões e sub-regiões, considerando dois períodos (2003-2009 e 2010-2016). A população do estudo incluía adultos entre 20 e 79 anos de idade, residentes em cada município da Colômbia no período de 2003-2016. As taxas de mortalidade suavizadas e padronizadas foram obtidas pelo ajuste de um modelo bayesiano hierárquico, levando em conta a estrutura espacial dos dados. Quatro variáveis socioeconômicas relacionadas à privação e ao desenvolvimento municipal foram incluídas no modelo para obter o risco relativo (RR) e intervalos de credibilidade de 95%. A mortalidade por diabetes mellitus tipo 2 diminuiu entre 2003 e 2016 na Colômbia, nos níveis tanto nacional quanto regional. Além disso, houve uma associação positiva entre mortalidade por diabetes mellitus e nível de desenvolvimento municipal; os municípios mais ricos e mais desenvolvidos apresentaram o maior risco de mortalidade.

Avaliação do risco para desenvolvimento de diabetes mellitus tipo 2 em estudantes universitários / Risk assessment for the development of Type 2 Diabetes Mellitus in college students

Introdução:Diabetes Mellitus tipo 2 é uma doença crônica, silenciosa, caracterizada por hiperglicemia causada pela produção insuficiente, ou resistência a ação da insulina. No Brasil, em 2017, diagnosticou 12,5 milhões de pessoas com diabetes mellitus, com uma prevalência de 8 a 9%, ocupando o quinto lugar no mundo. Dianteda transição nutricional, várias pesquisas tem demonstrado prevalência desta patologia em crianças, adolescentes e jovens. Objetivo:Identificar o risco de desenvolver Diabetes mellitus tipo 2 nos estudantes do curso de Biomedicina, da Faculdade Unigran Capital, Campo Grande, MS. Método:Trata-se de um Estudo Epidemiológico Descritivo Quantitativo Transversal, com uma amostra de 132 estudantes, através da aplicação de um questionário, determinação de glicemia capilar, coleta do peso, altura, cintura abdominal, e aferição da pressão arterial. Resultados:Foi identificado fatores de riscos importantes nos estudantes de biomedicina: obesidade, sedentarismo, hipertensão, consumo de dieta não saudável e a predisposição genética. Os homens apresentaram mais fatores dos que as mulheres, as faixas etárias mais jovens de 18-20 anos encontravam-se mais sedentários e mais obesos, e, as faixas etárias mais velhas apresentaram hipertensão e consumo de dieta não saudável. Conclusões:Há necessidade de promover medidas de prevenção: consumo de dieta saudável e prática de atividade física entre os estudantes, para evitar o desenvolvimento desta patologia (AU).

Introduction:Type 2 Diabetes Mellitus is a chronic silent disease characterized by hyperglycemia caused by insufficient production, or resistance to the action of insulin. In Brazil, in 2017, diagnosed 12.5 million people with Diabetes Mellitus, with prevalence of 8 to9%, ranking fifth in the world. Faced with the nutritional transition, several studies have demonstrated the prevalence of this pathology in children, adolescents and young people. Objective:To identify the risk of developing Type 2 Diabetes Mellitus instudents of Biomedicine, Faculty of Unigran Capital, Campo Grande, MS.Methods:This is an Epidemiological Descriptive Cross-Sectional Study, with a sample of 132 students, through the application of a questionnaire, determination of capillary glycemia, weight, height, abdominal waist, and blood pressure measurement. Results:: Important risk factors were identified in biomedicine students: obesity, sedentary lifestyle, hypertension, consumption of unhealthy diet and genetic predisposition. Males presentedmore factors than females, the younger age groups of 18-20 years were more sedentary and more obese, and the older age groups presented hypertension and unhealthy diet consumption.Conclusions:There is a need to promote prevention measures: consumption of healthy diet and practice of physical activity among students, to avoid the development of this pathology (AU).